Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in Am J Respir Crit Care Med

Retrieve available abstracts of 74 articles:
HTML format
Text format



Single Articles


    March 2017
  1. DEDICOAT MJ, Gunther G, Crudu V, Duarte R, et al
    Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.
    Am J Respir Crit Care Med. 2017 Mar 21. doi: 10.1164/rccm.201612-2585.
    PubMed     Text format    


    February 2017

  2. What is Tuberculosis (TB)?
    Am J Respir Crit Care Med. 2017;195:P7-P8.
    PubMed     Text format    


    December 2016
  3. NEBENZAHL-GUIMARAES H, van Laarhoven A, Farhat MR, Koeken VA, et al
    Transmissible Mycobacterium tuberculosis Strains Share Genetic Markers and Immune Phenotypes.
    Am J Respir Crit Care Med. 2016 Dec 20. doi: 10.1164/rccm.201605-1042.
    PubMed     Text format     Abstract available


  4. DARTOIS V, Saito K, Warrier T, Nathan C, et al
    New Evidence for the Complexity of the Population Structure of Mycobacterium tuberculosis Increases the Diagnostic and Biologic Challenges.
    Am J Respir Crit Care Med. 2016;194:1448-1451.
    PubMed     Text format    


    November 2016
  5. LEU JS, Chen ML, Chang SY, Yu SL, et al
    SP110b Controls Host Immunity and Susceptibility to Tuberculosis.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  6. HARAUSZ EP, Garcia-Prats AJ, Seddon JA, Schaaf HS, et al
    New/Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis: Practice-Based Recommendations.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  7. GUGLIELMETTI L, Le Du D, Frechet-Jachym M, Mitnick C, et al
    Preventing Acquired Resistance to Bedaquiline and Delamanid in Multidrug-Resistant Tuberculosis Treatment Requires Optimal Management.
    Am J Respir Crit Care Med. 2016;194:1170-1171.
    PubMed     Text format    


  8. SAUNDERS MJ, Datta S
    Contact Investigation: A Priority for Tuberculosis Control Programs.
    Am J Respir Crit Care Med. 2016;194:1049-1051.
    PubMed     Text format    


    October 2016
  9. VARAINE F, Guglielmetti L, Huerga H, Bonnet M, et al
    Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations.
    Am J Respir Crit Care Med. 2016;194:1028-1029.
    PubMed     Text format    


    September 2016
  10. SMALL PM
    Making Tuberculosis Care and Control Easy Again.
    Am J Respir Crit Care Med. 2016;194:537-538.
    PubMed     Text format    


    August 2016
  11. METERSKY ML, Schluger NW
    New Guidelines for the Treatment of Drug-susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and the Infectious Disease Society of America: Now Comes the Hard Part.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format    


  12. WHALEN CC
    The Replacement Principle of Tuberculosis. Why Prevention Matters.
    Am J Respir Crit Care Med. 2016;194:400-1.
    PubMed     Text format    


  13. FOIS A, Trisolini R, Canu S, Pirina P, et al
    Tuberculosis-induced Fish-scale Degeneration of the Central Airways.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format    


    July 2016
  14. KOENIG SP, Furin J
    Update in Tuberculosis/Pulmonary Infections 2015.
    Am J Respir Crit Care Med. 2016;194:142-6.
    PubMed     Text format    


  15. CHENGALROYEN MD, Beukes GM, Gordhan BG, Streicher EM, et al
    Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Tuberculosis Patients.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


    June 2016
  16. ZENNER D, Ashkin D
    Diagnosis of Latent Tuberculosis Infection in HIV-infected Pregnant Women. "Baby Steps" toward Better Tuberculosis Control in Pregnancy.
    Am J Respir Crit Care Med. 2016;193:1332-3.
    PubMed     Text format    


  17. WILKINSON KA, Oni T, Gideon HP, Goliath R, et al
    Activation Profile of Mycobacterium tuberculosis-Specific CD4(+) T Cells Reflects Disease Activity Irrespective of HIV Status.
    Am J Respir Crit Care Med. 2016;193:1307-10.
    PubMed     Text format    


    May 2016
  18. MARTINEZ L, Sekandi JN, Castellanos ME, Zalwango S, et al
    Infectiousness of HIV Seropositive Tuberculosis Patients in a High-burden African Setting.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


    February 2016
  19. FARHAT MR, Sultana R, Iartchouk O, Bozeman S, et al
    Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  20. GHASSEMIEH BJ, Attia EF, Koelle DM, Mancuso JD, et al
    Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  21. BUSCH M, Herzmann C, Kallert S, Zimmermann A, et al
    Lipoarabinomannan-responsive Polycytotoxic T Cells are Associated With Protection in Human Tuberculosis.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  22. MANCUSO JD, Diffenderfer JM, Ghassemieh BJ, Horne DJ, et al
    The Prevalence of Latent Tuberculosis Infection in the United States.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  23. HOFFMANN H, Kohl TA, Hofmann-Thiel S, Merker M, et al
    Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee.
    Am J Respir Crit Care Med. 2016;193:337-40.
    PubMed     Text format    


    January 2016
  24. MATHAD JS, Bhosale R, Balasubramanian U, Kanade S, et al
    Quantitative IFN-gamma,IL-2 Response and Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


    December 2015
  25. MATTHEWS K, Deffur A, Ntsekhe M, Syed F, et al
    A Compartmentalized Profibrotic Immune Response Characterizes Pericardial Tuberculosis, Irrespective of HIV-1 Infection.
    Am J Respir Crit Care Med. 2015;192:1518-1521.
    PubMed     Text format    


    October 2015
  26. KING TC, Upfal M, O'Dea LS
    Reply: Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:1022-1023.
    PubMed     Text format    


  27. OLARU ID, Lange C, Sester M
    Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:1021-1022.
    PubMed     Text format    


  28. CUSUMANO G, Bellofiore S, Montineri A, Emanuele R, et al
    Pott's Disease of the Thoracic Spine and Abscess of the Chest Wall.
    Am J Respir Crit Care Med. 2015;192:e51-2.
    PubMed     Text format    


  29. ELKINGTON P, Zumla A
    Update in Mycobacterium tuberculosis Lung Disease 2014.
    Am J Respir Crit Care Med. 2015;192:793-798.
    PubMed     Text format    


    September 2015
  30. GLEESON LE, Keane J
    First Steps in Biomarker Assessment for Reactivation Risk in Latent Tuberculosis Infection.
    Am J Respir Crit Care Med. 2015;192:534-5.
    PubMed     Text format    


  31. GRIFFITH DE
    Nontuberculous Mycobacterial Disease Research. An End to the Beginning.
    Am J Respir Crit Care Med. 2015;192:535-7.
    PubMed     Text format    


  32. SZYMANSKI EP, Leung JM, Fowler CJ, Haney C, et al
    Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.
    Am J Respir Crit Care Med. 2015;192:618-28.
    PubMed     Text format     Abstract available


    August 2015
  33. MURRAY JF
    Tuberculosis and World War I.
    Am J Respir Crit Care Med. 2015;192:411-4.
    PubMed     Text format    


  34. GOMEZ-PASTRANA D, Dominguez J
    Diagnosis of Tuberculosis in Children Using Mycobacteria-Specific Cytokine Responses. Are There Reasons for Hope?
    Am J Respir Crit Care Med. 2015;192:409-10.
    PubMed     Text format    


  35. BOEREE MJ, Diacon AH, Dawson R, Narunsky K, et al
    A Step toward an Optimized Rifampin Dose Completed.
    Am J Respir Crit Care Med. 2015;192:525-6.
    PubMed     Text format    


  36. MILLER SL
    Upper Room Germicidal Ultraviolet Systems for Air Disinfection Are Ready for Wide Implementation.
    Am J Respir Crit Care Med. 2015;192:407-9.
    PubMed     Text format    


  37. TEBRUEGGE M, Dutta B, Donath S, Ritz N, et al
    Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:485-99.
    PubMed     Text format     Abstract available


  38. GARCIA-BASTEIRO AL, Ismail MR, Carrilho C, Ussene E, et al
    "Pomegranate" Spleen in Disseminated Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:387-388.
    PubMed     Text format    


  39. KING TC, Upfal M, Gottlieb A, Adamo P, et al
    T-SPOT.TB Interferon-gamma Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals.
    Am J Respir Crit Care Med. 2015;192:367-73.
    PubMed     Text format     Abstract available


    July 2015
  40. BOTHAMLEY GH
    Fluoroquinolone Preventive Therapy after Exposure to Multidrug-Resistant Tuberculosis? Hopes and Fears.
    Am J Respir Crit Care Med. 2015;192:131-2.
    PubMed     Text format    


  41. GEBHARD A, van den Hof S, Cobelens F
    How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Am J Respir Crit Care Med. 2015;192:117.
    PubMed     Text format    


  42. BASTARD M, Bonnet M, du Cros P, Khamraev AK, et al
    Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Am J Respir Crit Care Med. 2015;192:117-118.
    PubMed     Text format    


  43. MUKHERJEE V, Bender WS, Egan JP 3rd
    Inhaled Antibiotics for Refractory Nontuberculous Mycobacteria and Non-Cystic Fibrosis Bronchiectasis and the Significance of Mycobacterium abscessus subsp. abscessus Isolation during M. avium Complex Lung Disease Therapy.
    Am J Respir Crit Care Med. 2015;192:106-108.
    PubMed     Text format    


  44. BISCHOF JE, Chingsanoon A, Nanthavong P, Vidhamaly S, et al
    Contained Rupture of a Tuberculous Mycotic Aortic Aneurysm Detected by Bedside Ultrasound.
    Am J Respir Crit Care Med. 2015;192:e1-e2.
    PubMed     Text format    


    June 2015
  45. CAMINERO JA, Migliori GB
    Automated Digital Microscopy in New Tuberculosis Diagnostic Algorithms. Can It Boost Case Finding?
    Am J Respir Crit Care Med. 2015;191:1352-3.
    PubMed     Text format    


  46. ESCALANTE P, Peikert T, Van Keulen VP, Erskine CL, et al
    Combinatorial Immunoprofiling in Latent Tuberculosis Infection: Toward Better Risk Stratification.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format     Abstract available


    May 2015

  47. Erratum: daily rifapentine for treatment of pulmonary tuberculosis: a randomized, dose-ranging trial.
    Am J Respir Crit Care Med. 2015;191:1210.
    PubMed     Text format    


  48. ACCINELLI RA, Romero LR, Garcia RF, Sanchez R, et al
    Sustained Benefit of Community-based Tuberculosis Interventions after 30 Years.
    Am J Respir Crit Care Med. 2015;191:1202-3.
    PubMed     Text format    


  49. VOSKUIL MI, Schlesinger LS
    Toward Resolving the Paradox of the Critical Role of the DosR Regulon in Mycobacterium tuberculosis Persistence and Active Disease.
    Am J Respir Crit Care Med. 2015;191:1103-5.
    PubMed     Text format    


  50. ZUMLA A, Maeurer M
    IFN-gamma Release Assays for Risk Assessment in Contacts of Patients with Tuberculosis in Low-Burden European Countries.
    Am J Respir Crit Care Med. 2015;191:1101-3.
    PubMed     Text format    


  51. MENZIES D
    Finishing what they started: when do researchers' responsibilities end?
    Am J Respir Crit Care Med. 2015;191:977-8.
    PubMed     Text format    


    April 2015
  52. MPHAPHLELE M, Dharmadhikari AS, Jensen PA, Rudnick SN, et al
    Institutional Tuberculosis Transmission: Controlled Trial of Upper Room Ultraviolet Air Disinfection - A Basis for New Dosing Guidelines.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format     Abstract available


  53. FOX GJ, Oxlade O, Menzies D
    Fluoroquinolone Therapy for the Prevention of Multi-drug Resistant Tuberculosis in Contacts: a Cost-effectiveness Analysis.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format     Abstract available


  54. DIACON AH, Dawson R, von Groote-Bidlingmaier F, Symons G, et al
    Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.
    Am J Respir Crit Care Med. 2015;191:943-53.
    PubMed     Text format     Abstract available


  55. GROSSET J, Vernon A
    A reader's guide to the bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.
    Am J Respir Crit Care Med. 2015;191:871-3.
    PubMed     Text format    


    March 2015
  56. ISMAIL NA, Omar SV, Lewis JJ, Dowdy DW, et al
    Performance of a Novel Algorithm Using Automated Digital Microscopy for Diagnosing Tuberculosis.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format     Abstract available


  57. ZELLWEGER JP, Sotgiu G, Block M, Dore S, et al
    Risk Assessment of Tuberculosis in Contacts by Interferon-gamma Release Assays (IGRAs). A TBNET Study.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format     Abstract available


  58. MEHRA S, Foreman TW, Didier PJ, Ahsan MH, et al
    The DosR Regulon Modulates Adaptive Immunity and is Essential for M. tuberculosis Persistence.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format     Abstract available


  59. CHANG CH, Ruan SY, Huang CT
    Disseminated tuberculosis in a patient treated with biologics.
    Am J Respir Crit Care Med. 2015;191:592-3.
    PubMed     Text format    


  60. ANDREWS JR, Hatherill M, Mahomed H, Hanekom WA, et al
    The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents.
    Am J Respir Crit Care Med. 2015;191:584-91.
    PubMed     Text format     Abstract available


    February 2015
  61. SLOOT R, Schim van der Loeff MF, Kouw PM, Borgdorff MW, et al
    Reply: Overestimation of Coprevalent and Underestimation of Incident Tuberculosis in Close Contacts.
    Am J Respir Crit Care Med. 2015;191:487.
    PubMed     Text format    


  62. HORSBURGH CR JR
    Overestimation of Coprevalent and Underestimation of Incident Tuberculosis in Close Contacts.
    Am J Respir Crit Care Med. 2015;191:486-487.
    PubMed     Text format    


  63. KANEKO Y, Nakayama K, Kinoshita A, Kurita Y, et al
    Relation between Recurrence of Tuberculosis and Transitional Changes in IFN-gamma Release Assays.
    Am J Respir Crit Care Med. 2015;191:480-483.
    PubMed     Text format    


  64. YABLONSKII PK, Vizel AA, Galkin VB, Shulgina MV, et al
    Tuberculosis in Russia. Its History and Its Status Today.
    Am J Respir Crit Care Med. 2015;191:372-376.
    PubMed     Text format     Abstract available


  65. BOEREE MJ, Diacon AH, Dawson R, Narunsky K, et al
    A Dose Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format     Abstract available


  66. BASTARD M, Bonnet M, du Cros P, Khamraev AK, et al
    Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?
    Am J Respir Crit Care Med. 2015;191:355-8.
    PubMed     Text format    


  67. LAUZARDO M, Ashkin D
    Optimizing the Dose of Rifapentine to Treat Tuberculosis. It's Elementary.
    Am J Respir Crit Care Med. 2015;191:251-2.
    PubMed     Text format    


    January 2015
  68. MANDALAKAS AM, Kirchner HL, Walzl G, Gie RP, et al
    Optimizing the Detection of Recent Tuberculosis Infection in Children in a High TB-HIV Burden Setting.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format     Abstract available


    December 2014
  69. DORMAN SE, Savic RM, Goldberg S, Stout JE, et al
    Daily Rifapentine for Treatment of Pulmonary Tuberculosis: a Randomized, Dose-ranging Trial.
    Am J Respir Crit Care Med. 2014.
    PubMed     Text format     Abstract available


  70. KELLY JD, Grace Lin SY, Barry PM, Keh C, et al
    Xpert MTB/RIF False Detection of Rifampin-Resistant Tuberculosis from Prior Infection.
    Am J Respir Crit Care Med. 2014;190:1316-8.
    PubMed     Text format    


    November 2014
  71. O'LEARY SM, Coleman MM, Chew WM, Morrow C, et al
    Cigarette Smoking Impairs Human Pulmonary Immunity to Mycobacterium tuberculosis.
    Am J Respir Crit Care Med. 2014.
    PubMed     Text format     Abstract available


  72. RIEBER N, Hartl D
    Eat and Suppress: The Two-Faced Role of Myeloid-derived Suppressor Cells in Tuberculosis.
    Am J Respir Crit Care Med. 2014;190:975-7.
    PubMed     Text format    


    October 2014
  73. JAMBO KC, Banda DH, Afran L, Kankwatira AM, et al
    Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria.
    Am J Respir Crit Care Med. 2014;190:938-47.
    PubMed     Text format     Abstract available


  74. GAUR RL, Banaei N
    Inoculation of QuantiFERON-TB tubes with skin microbiota causes false-positive results.
    Am J Respir Crit Care Med. 2014;190:834-7.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: